Stimulation of immune response with low doses of cytokines
US6509313B1 · kind B1 · utility
68Cited by
14References
57Claims
0Family size
Assignee
Inventor
Key dates
| Filing date | May 7, 1996 |
| Grant date | Jan 21, 2003 |
| Priority date | — |
| Expiry date | May 7, 2016 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61K9/7023
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
A method of activating the immune system of a subject comprises the chronic administration of low doses of an agent having cytokine activity, including natural and recombinant cytokines, fragments, analogues, fusion proteins, and derivatives thereof, that are pharmaceutically acceptable, and their mixtures with other biologically active agents and formulation ingredients. The agent is provided as a unit dosage form, in systemic and topical product form, as an implant, inhalant, transdermal delivery device, and ultrasound and electrotransport devices, as well as in the form of a kit for self-administration.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.